Skip to main content
Signal8

Holmen Bob

SEC insider (Form 3/4/5 filer). CIK 0001843508. Director at Sensei Biotherapeutics, Inc. (SNSE). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in ROCKVILLE, MD.

Companies Holmen Bob has filed insider reports for

  • Sensei Biotherapeutics, Inc. (SNSE): Director
Holmen Bob profile photo

Holmen Bob

CIK: 0001843508

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sensei Biotherapeutics, Inc. logo
SNSE

Sensei Biotherapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Sensei Biotherapeutics, Inc. logo
    SNSE

    Sensei Biotherapeutics, Inc.

    Jun 10, 2026
    Award

    Stock Option (right to buy)

    Direct
    12.5K shares-
  • Sensei Biotherapeutics, Inc. logo
    SNSE

    Sensei Biotherapeutics, Inc.

    May 21, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    19K shares-

1-2 of 2